Schedule 13G ownership disclosure

ADAPTIVE BIOTECHNOLOGIES CORP

Security class unavailable · CUSIP: 00650F109

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
650,000
Percent of class
0.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006448
Form type
SC 13G/A
Filer
Adaptive Biotechnologies Corp
CIK
CIK 1478320
Filed
Nov 13, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub